Safety Study of GNbAC1 Monoclonal Antibody in Healthy Male Volunteers

Inclusion Criteria: * Healthy male subjects as determined by past medical history, physical examination, vital signs, ECG and laboratory tests at Screening and confirmed at Day -1 who have signed the informed consent. * Aged from 18 to 55 years, both inclusive. Exclusion Criteria: * History of serious adverse reactions or hypersensitivity to any drug. * Presence or history of any allergy requiring acute or chronic treatment (seasonal allergic rhinitis that requires no treatment may be tolerated). * Need of any prescription medication within 15 days prior to the administration of the study drug and/or non-prescription medication within 7 days prior to the administration of the study drug or anticipated need for any concomitant medication during the study. * Participation in a clinical trial during the previous 3 months, i.e. from completion of the previous trial to the planned first administration of the current trial. NOTE: Other protocol-defined Inclusion/Exclusion criteria may apply.